目的:对进口精蛋白锌重组赖脯胰岛素混合注射液进行质量分析。方法:对2018~2020年经苏州口岸进口的129批(722件)精蛋白锌重组赖脯胰岛素混合注射液的有关物质、苯酚和间甲酚、可溶性赖脯胰岛素、含量、锌、高分子蛋白质、pH等质量参数进行统计分析,并对结果进行趋势分析。结果:精蛋白锌重组赖脯胰岛素混合注射液(25R)36批352件,占48.8%,精蛋白锌重组赖脯胰岛素混合注射液(50R)93批370件,占51.2%。722件精蛋白锌重组赖脯胰岛素混合注射液关键参数检测结果主要位于平均值±2SD区间。苯酚和间甲酚、可溶性赖脯胰岛素、含量、锌、pH等均未超过平均值±3SD,但部分批次产品的有关物质和高分子蛋白质超过平均值±3SD。结论:精蛋白锌重组赖脯胰岛素混合注射液总体情况稳定,质量较好。
张国林, 王思渊, 田沛霖, 鲁辉, 李玥琦, 徐铠琳, 戴国英, 张斌, 周忆新, 邢以文, 薛满
. 722件进口精蛋白锌重组赖脯胰岛素混合注射液质量研究*[J]. 药物分析杂志, 2021
, 41(11)
: 2039
-2048
.
DOI: 10.16155/j.0254-1793.2021.11.23
Objective: To analyze the quality of imported mixed protamine zinc recombinant insulin lispro injection. Methods: The related substances, phenol and m-cresol, soluble insulin lispro, content, zinc, high molecular protein, pH value and other quality parameters of 129 batches (722 pieces) of mixed protamine zinc recombinant insulin lispro injection imported through Suzhou port from 2018 to 2020 were statistically analyzed. Results: There were 352 pieces of protamine zinc recombinant insulin lispro mixed injection (25R) in 36 batches, accounting for 48.8%. There were 370 pieces of spermine zinc recombinant insulin lispro mixed injection (50R) in 93 batches, accounting for 51.2%. The key parameters of 722 pieces of protamine zinc recombinant insulin lispro mixed injection were mainly in the range of ±2SD. Phenol, m-cresol, soluble insulin lispro, content, zinc, pH value were not more than the average value ±3SD, but the related substances and high molecular protein of some batches of products exceeded the average±3 SD. Conclusion: Generally speaking, the quality of mixed protamine zinc recombinant insulin lispro injection was stable and good.
[1] RODEN M, SHULMAN GI. The integrative biology of type 2 diabetes[J].Nature, 2019, 576(7785):51
[2] FLANNICK J, MERCADER JM, FUCHSBERGER C, et al. Exome sequencing of 20, 791 cases of type 2 diabetes and 24,440 controls[J].Nature, 2019, 570(7759):71
[3] 陈海静,孙海燕,刘红丹.精蛋白锌重组赖脯胰岛素混合注射液治疗初发2型糖尿病的疗效及安全性观察[J].中国药师,2016,19(8):1502
CHEN HJ, SUN HY, LIU HD. Efficacy and safety of mixed protamine zinc recombinant human insulin injection in the treatment of newly diagnosed type 2 diabetes mellitus[J].China Pharm, 2016, 19(8):1502
[4] 张爱鸣,历钗微.精蛋白锌重组赖脯胰岛素混合注射液(50R)治疗2型糖尿病60例[J].中国新药杂志,2010,19(6):509
ZHANG AM, LI CW. Efficacy of mixed protamine zinc recombinant human insulin lispro injection (50R) in 60 patients with type 2 diabetes mellitus[J].Chin J New Drugs, 2010, 19(6):509
[5] 梅丽,蒋玲,杨桦,等.精蛋白锌重组赖脯胰岛素混合注射液(25R)稳定性研究[J].生物化工,2018,4(3):78
MEI L, JIANG L, YANG H, et al. Stability of mixed protamine zinc recombinant human insulin lispro injection (25 R) in simulated clinical use[J].Biol Chem Eng, 2018, 4(3):78
[6] 王开芹,孙卓浩,谢大帝.利拉鲁肽注射液联合精蛋白锌重组赖脯胰岛素混合注射液(50R)治疗肥胖型2型糖尿病患者的临床研究[J].中国临床药理学杂志,2020,36(15):2205
WANG KQ, SUN ZH, XIE DD. Research on efficacy and safety of domestic mixed protamine zinc recombination human insulin lispro injection (25R) in treatment of diabetes[J].Chin J Clin Pharmacol, 2020, 36(15):2205
[7] 潘长玉,陆菊明,韩萍,等.国产精蛋白锌重组赖脯胰岛素混合注射液(25R)治疗糖尿病的有效性和安全性研究[J].中国医院用药评价与分析,2019,19(7):828
PAN CY, LU JM, HAN P, et al. Research on efficacy and safety of domestic mixed protamine zinc recombination human insulin lispro injection (25R) in treatment of diabetes[J].Eval Anal Drug Hosp Chin, 2019,19(7):828
[8] JS20190107.进口药品注册标准 [S]. 2019
JS20190107.National Import Drug Standards[S]. 2019
[9] JS20160060.进口药品注册标准[S]. 2016
JS20160060.National Import Drug Standards[S]. 2016
[10] 马霄, 孟丽, 谭亚军,等. 趋势分析在疫苗产品批签发管理中的应用[J].中国药事,2014,28(7):750
MA X, MENG L, TAN YJ, et al. Application of trend analysis method for vaccine lot release [J].Chin Pharm Aff, 2014, 28(7):750
[11] 中华人民共和国药典2020年版[S]. 2020
ChP 2020 [S]. 2020
[12] 丁晓丽, 宋敏, 张慧, 等. 精蛋白锌胰岛素注射液中硫酸鱼精蛋白含量测定的方法研究[J].药物分析杂志,2012,32(4):679
DING XL, SONG M, ZHANG H, et al. Study on determination of protamine sulfate in protamine zine insulin injection [J].Chin J Pharm Anal,2012,32(4):679
[13] 杨庆,马鲁南,刘忠,等.分子排阻色谱法测定德谷胰岛素高分子蛋白含量[J].中国现代应用药学,2020,37(23):2879
YANG Q, MA LN, LIU Z, et al. Quantitation of high molecular weight proteins in insulin degludec by size exclusion chromatography[J].Chin J Mod Appl Pharm, 2020, 37(23):2879
[14] 刘思光,徐勤娟,赵亮亮,等.UPLC法Hilic模式下测定促胰岛素分泌肽类似物(Ex4c)有关物质[J].中国新药杂志,2017,26(20):2396
LIU SG, XU QJ, ZHAO LL, et al. Determination of related substances of insulinotropic peptide analogue (Ex4c) in Hilic mode by UPLC[J].Chin J New Drugs, 2017, 26(20):2396
[15] 辛中帅,丁晓丽,任雪,等.HPLC法测定地特胰岛素有关物质及主要杂质鉴别[J].药物分析杂志,2014,34(8):1497
XIN ZS, DING XL, REN X, et al. HPLC determination of related substances and identification of main impurity in insulin detemir[J].Chin J Pharm Anal, 2014, 34(8):1497
